COVID-19 Clinical Trials

Clinical trials help researchers develop new and better treatments. The information they provide is the only way for medical breakthroughs to reach the public. During the current COVID-19 pandemic, it’s vital that patients and healthy volunteers participate in research related to the virus and its effects on our physical and mental health.

At this time, we invite to you open a profile through MyChart so that we are able to know your preferred areas of interest so our recruitment team may contact you with trials as they become available.

If you have questions or concerns, please contact us at helpusdiscover@yale.edu or call 1-877-978-8343.

COVID-19 Clinical Trials

PediatricsA Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma
Urinary BladderA Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Phase IAn Open-label, Phase I/IIa First-in-human, Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Antitumour Activity of ERK1/2 Inhibitor IPN01194 as Single Agent in Adult Participants With Advanced Solid Tumours
Non-Hodgkin's LymphomaSoquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Soft TissueA Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma